Document Detail


Oestrogen attenuates coronary vasoconstriction after angioplasty: role of endothelin-1.
MedLine Citation:
PMID:  11895463     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND AIMS: There were controversies as to whether endothelin-1 is released after coronary angioplasty. We sought to determine whether endothelin-1 is released after coronary angioplasty and whether oestrogen administration can affect coronary vasomotor tone by reducing endothelin-1 concentrations. METHODS: The study was designed to prospectively investigate 24 consecutive patients scheduled for elective coronary angioplasty. Patients were randomized into two groups according to whether they did not (group 1, n = 12) or did (group 2, n = 12) have intracoronary treatment with oestrogen. Quantitative coronary angiography was monitored at baseline, immediately after successful angioplasty, and 15 min after the last deflation. Blood samples for measuring the levels of endothelin-1 were drawn from the ascending aorta and the coronary sinus simultaneously before angioplasty and 15 min after balloon dilatation. RESULTS: The diameters of the coronary artery at the dilated segments were significantly reduced 15 min after dilation compared with those immediately after dilation in group 1 from 3.20 +/- 0.22 to 2.30 +/- 0.23 mm (P < 0.001), respectively. The vasoconstriction was significantly blunted in group 2. The endothelin-1 levels from the coronary sinus rose significantly, by 29%, 15 min after angioplasty in group 1, which was attenuated after administering oestrogen. Significant correlation was found between the changes of coronary vasomotion of the dilated segment and endothelin-1 levels (r = 0.70, P = 0.01). CONCLUSION: Endothelin-1 is released into the coronary circulation after angioplasty, and this vasoactive substance may contribute to the occurrence of vasoconstriction. The vasoconstriction is attenuated by oestrogen by reducing the endothelin-1 levels. This finding provided a new strategy to treat coronary vasoconstriction after angioplasty.
Authors:
T-M Lee; S-F Su; C-H Tsai
Related Documents :
2956393 - Serial coronary angioplasty for atherosclerosis following heart transplantation.
10490553 - Spectrum of reperfusion strategies and factors influencing the use of primary angioplas...
733363 - Advances in invasive cardiac diagnosis and management.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  European journal of clinical investigation     Volume:  32     ISSN:  0014-2972     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2002 Mar 
Date Detail:
Created Date:  2002-03-15     Completed Date:  2002-06-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  141-7     Citation Subset:  IM    
Affiliation:
National Taiwan University Hospital, 7 Chung-Shan S. Road, Taipei, Taiwan 10002.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary*
Aorta / metabolism
Blood Pressure
Coronary Artery Disease / blood,  diagnosis,  therapy*
Coronary Vessels / metabolism*
Electrocardiography
Endothelin-1 / blood*
Estrogens / administration & dosage*
Female
Humans
Lactates / blood
Male
Middle Aged
Myocardial Ischemia / blood,  diagnosis,  therapy
Prospective Studies
Sinus of Valsalva / metabolism
Vasoconstriction / drug effects*,  physiology
Chemical
Reg. No./Substance:
0/Endothelin-1; 0/Estrogens; 0/Lactates

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new insight into aspirin-induced asthma.
Next Document:  Elective coronary angioplasty with 60 s balloon inflation does not cause peroxidative injury.